Skip to main content

Advertisement

Table 1 Clinical features of type 2 diabetes and control groups

From: Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control

  Control subjects Type 2 diabetes P
N 22 10  
Age (years) 61.5 ± 5.5 62.2 ± 7.5 P = 0.76
M:F 15:7 8:2  
Diabetes duration (years) - 6.5 (7.75)  
BMI (kg/m2) 26.6 ± 4.5 28.1 ± 6.9 P = 0.46
HbA1c (%) - 6.9 ± 0.7  
Systolic blood pressure(mmHg) 145.8 ± 21.8 144.7 ± 16.9 P = 0.88
Diastolic blood pressure(mmHg) 89.6 ± 11.3 80.1 ± 9.3 P = 0.03
Statin use (n) 5 9 P = 0.0005
ACE inhibitors (n) 2 4 P = 0.05
Aspirin (n) 3 6 P = 0.01
  1. Data are means ± SD or median (interquartile range).
  2. BMI – body Mass Index
  3. HbA1c – glycosylated hemoglobin